Lee J. Helman, M.D., Scientific Director for Clinical Research, Center for Cancer Research

Human biology continues to amaze and often baffle us as we struggle to unravel it and reduce the cancer burden. Yet understanding cancer biology is only half the battle: We must translate that knowledge into clinically meaningful applications. Reaching that goal requires a strategic interdisciplinary and multidisciplinary effort to bridge critical basic science with clinical care.

The National Cancer Institute’s own clinical cancer program, under the direction of the Center for Cancer Research (CCR), sits squarely at the intersection of exploding basic cancer biology knowledge and new cancer treatments. Although we may not have the same name recognition as other national cancer centers, which are primarily large volume, full-service cancer treatment hospitals and clinics, we are in fact the largest cancer-focused clinical research center in the world. But we are not a traditional cancer care center that happens to do research: Our sole mission is to perform patient-intensive clinical research aimed at translating the explosion of new scientific insights into new approaches to prevent, diagnose, and treat cancer.

One of our greatest strengths is our unmatched broad integration of basic and clinical scientists. This combination is particularly powerful at NCI, where basic laboratories adjoin clinical wards. Thanks to this tight collaboration of researchers across disciplines and settings, we are uniquely able to knit together insights from preclinical disease models with science-based approaches to human clinical treatment. This ability is especially true in understudied cancers, although our findings often have relevance to many cancers and even other diseases. Our collaborative model allows us to identify new cancer therapies, both single agents and combinations, and bring them rapidly through early development and clinical testing and, if successful, partner with extramural collaborators to ensure that they are quickly brought to widespread trials and hopefully into clinical practice. Our structure also uniquely enables us to find novel ways to detect cancer early and even prevent it, largely through building powerful new imaging technologies that allow us to “see” cancer even in its initial stages.

But perhaps the most important collaborative partners of all, the ones who truly make the NCI cancer clinical research center unique from all others, are the patients who come to us. They come here seeking to actively participate in research with our basic and clinical scientists to drive understanding of their cancer and, ultimately, to find an effective treatment — if not for them, then for others. We are proud to work with them — it is their hope and focus that drives us every day. If — when — we succeed in our mission, it is clear that the lion's share of the credit must go to them.

Committed to Cancer Research

Not finding what you're looking for?
Comments and feedback are welcome. Please send suggestions to web.edits@mmgct.com.

Want to unsubscribe or change your e-mail profile and interests?
Please visit our site and change your e-mail preferences if you are on our list in error, would like to unsubscribe, or would like to change your e-mail profile and interests.

This mailing has been approved by the Office of Patient Outreach and Recruitment, Center for Cancer Research, NCI, Building 10 - CRC, Room 3-2571, Mail Stop 1206, 10 Center drive, Bethesda, MD, 20892.